spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  intracranial bleeding 

 HSMN NewsFeed - 12 Dec 2022
IRRAS Receives US FDA 510(k) Clearance for its Next Generation IRRAflow Control Unit
Devices Neurosurgery FDA
 HSMN NewsFeed - 23 Aug 2022
IRRAS Announces First Patient Treatments at Mount Sinai Health System in New York as Part of the DIVE Study
Devices Neurosurgery Monitoring
 HSMN NewsFeed - 28 May 2021
IRRAS Announces publication of a Case report from Buffalo General Medical Center, highlights clinical superiority of IRRAflow treatment versus traditional drainage
Devices Neurosurgery Monitoring
 HSMN NewsFeed - 6 Apr 2021
IRRAS Announces Collaboration with Aarhus University Hospital, Scandinavian Leader in Neurosurgery, to Advance Use of IRRAflow
Devices Neurosurgery Monitoring
 HSMN NewsFeed - 17 Dec 2020
IRRAS Announces Expansion of IRRAflow Launch to Southeastern Europe
Devices Neurosurgery Distribution
 HSMN NewsFeed - 25 Mar 2020
University of Helsinki, a Global Neurosurgery Leader and IRRAS Will Collaborate to Advance Uses of IRRAflow
Devices Neurosurgery Monitoring
 HSMN NewsFeed - 7 Jan 2020
IRRAS Provides US Launch Update, Product Portfolio Progress and Objectives for 2020
Devices Neurosurgery Monitoring
 HSMN NewsFeed - 24 Apr 2019
IRRAS Provides Update on CE Mark Re-Certification of IRRAflow(R)
Devices Neurosurgery Regulatory
 HSMN NewsFeed - 13 Sep 2017
IRRAS Strengthens Executive and Commercial Teams with Appointments of Karl-Matthias Moehlmann and Klemens Fölling
Devices Neurology Personnel
 HSMN NewsFeed - 30 Aug 2017
IRRAS Appoints Fredrik Alpsten as Chief Financial Officer and Deputy CEO
Devices Neurosurgery Monitoring Personnel
 HSMN NewsFeed - 30 Aug 2016
Portola Pharmaceuticals Announces Interim Results from Ongoing Phase 3b/4 ANNEXXA-4(TM) Study of Factor Xa Inhibitor Antidote AndexXa(TM) (andexanet alfa) in Patients with Acute Major Bleeding
Biopharmaceuticals
 HSMN NewsFeed - 16 Jan 2013
InfraScan Receives FDA Approval of Next Generation, Noninvasive Handheld Brain Hematoma Detector
Devices Neurosurgery FDA
 HSMN NewsFeed - 30 Aug 2009
New Large-Scale, Global Study Provides Additional Information About an Intensified Dose-Regimen of Plavix(R) in Acute Coronary Syndrome Patients Undergoing Angioplasty
Biopharmaceuticals Interventional Cardiology
 HSMN NewsFeed - 27 Aug 2009
NeuroVasx Receives Canadian Approval for cPAX Aneurysm Treatment System
Devices Interventional Neurology Regulatory
 HSMN NewsFeed - 25 Mar 2009
NeuroVasx Receives CE Mark for cPAX Aneurysm Treatment System
Devices Neurology Interventional Regulatory
 HSMN NewsFeed - 2 Sep 2008
New Data Shows Anticlotting Medicine, AGGRASTAT(R), Lowers Incidence of Heart Attack, in Patients Who Respond Poorly to Aspirin or Clopidogrel, after Elective Coronary Angioplasty
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 17 Sep 2007
Updated REVLIMID(R) Clinical Results Presented at the 12th International Workshop on Chronic Lymphocytic Leukemia
Biopharmaceuticals Oncology
 HSMN NewsFeed - 18 Jun 2007
NeuroVasx, Inc. Announces 510(k) FDA Submission of its cPAX Aneurysm Treatment System(TM) for Treatment of Cerebral Aneurysms
Devices Interventional Neurology
 HSMN NewsFeed - 31 May 2007
Topline Results of Phase III Study in Acute Ischemic Stroke (Dias-2) Do Not Demonstrate Difference Between Desmoteplase and Placebo
Biopharmaceuticals Neurology
 HSMN NewsFeed - 20 Apr 2007
The Lancet Publishes PREVAIL Study Results Showing Lovenox(R) Superiority Over Unfractionated Heparin for Reducing the Risk of Venous ThromboEmbolism in Patients With Acute Ischemic Stroke
Biopharmaceuticals
 HSMN NewsFeed - 12 Dec 2006
New Study Shows Clexane(R) / Lovenox(R) (Enoxaparin Sodium Injection) is More Effective Than Unfractionated Heparin (UFH) for Preventing the Risk of Venous Thromboembolism (VTE) in Patients With Acute Ischemic Stroke
Biopharmaceuticals
 HSMN NewsFeed - 12 Dec 2006
New Study Shows Lovenox(R) (Enoxaparin Sodium Injection) Is More Effective Than Unfractionated Heparin (UFH) for Lowering the Risk of Venous Thromboembolism (VTE) in Patients With Acute Ischemic Stroke
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 13

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 13 additional stories matching:
intracranial bleeding
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!